Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Metastatic breast cancer treated by combination of pemetrexed and gemcitabine
March 23rd, 2006
Metastatic breast cancer could be treated by a combination of pemetrexed and gemcitabine. "This phase II study was undertaken to define the efficacy and toxicity of pemetrexed in combination with gemcitabine in patients with metastatic breast cancer. Patients with measurable metastatic breast cancer who had previously received an anthracycline and a taxane in either the adjuvant or metastatic setting were treated with gemcitabine 1250 mg/m2 (intravenous; days 1 and 8) and pemetrexed 500 mg/m2 (intravenous; day 8) every 21 days," researchers in the United States reported. "Fifty-nine patients received a median of 5 cycles (range...
Source: Women's Health Weekly (2006-03-23)
|
